C92.0
Acute myeloblastic leukemia
C92.0 is a non-billable ICD-10-CM code header for acute myeloblastic leukemia. Report a more specific code from it instead. It is part of the FY2027 code set, effective October 1, 2026. The more specific codes under it are C92.00 Acute myeloblastic leukemia, not having achieved remission; C92.01 Acute myeloblastic leukemia, in remission and C92.02 Acute myeloblastic leukemia, in relapse. Its coding notes include a Code also instruction, 3 Excludes1 entries and 4 Excludes2 entries.
Guidelines tip
From the FY2027 Official Guidelines. ICD10Ref adds no rules of its own.
Leukemia and myeloma codes show whether remission has been achieved. If the documentation is unclear, the Guidelines say to query the provider.
Code also
Two codes may be needed to describe the condition. This note gives no sequencing order.
Excludes1
Not coded here. The listed conditions generally should not be reported together.
Excludes2
Not included here. Both codes may be reported if the patient has both conditions.
Also from chapter/block level (4 notes)
Includes
Further defines or gives examples of the content of the category.
- granulocytic leukemia
- myelogenous leukemia
Inclusion terms
Conditions classified to this code.
- Acute myeloblastic leukemia, minimal differentiation
- Acute myeloblastic leukemia (with maturation)
- Acute myeloblastic leukemia 1/ETO
- Acute myeloblastic leukemia M0
- Acute myeloblastic leukemia M1
- Acute myeloblastic leukemia M2
- Acute myeloblastic leukemia with t(8;21)
- Acute myeloblastic leukemia (without a FAB classification) NOS
- Refractory anemia with excess blasts in transformation [RAEB T]
Notes
Also from chapter/block level (8 notes)
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Alphabetic Index terms
Terms the official Alphabetic Index lists for this code. 5 entries